At Cerveau Technologies, we facilitate access to a broad array of informatics and technology. With as many leading scientists as feasible, cost effective and efficiently as possible; we encourage research projects and publishable data that can be utilized for product positioning, enhanced clinical application and eventual commercialization.
Accelerate clinical development roadmap effectively and efficiently, as well as explore additional indications and applications
Develop global commercial strategies and collaborations to ensure rapid product penetration
Develop and support international research network of student exchange programs and training initiatives utilizing global university network
Want to learn more about us?
Enigma Biomedical Group Signs Research Agreement with Austin Health
Business Wire — March 23, 2017
Cerveau Technologies, Inc. Executes a Binding Term Sheet with Sinotau Pharmaceutical Group for Novel Investigational Tau Imaging Agent
Business Wire — March 17, 2017
Cerveau Technologies, Inc. Signs Research Agreement with Wisconsin Alzheimer’s Disease Research Center
Business Wire — March 6, 2017
Enigma Biomedical Group Signs Research Agreement with McGill University Research Centre for Studies in Aging
Business Wire — February 20, 2017
Read More Press Releases